1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
34.54 -4.71 (-12.00%)
30.39% Fall from 52W High
9.4M
XNAS Volume
High volume+loss today

XNAS 20 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Exelixis Inc is on 29 Oct 2025 for the purpose of Exelixis Inc Third Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Mid Valuation
49.5 / 100
Momentum Score
Technically Neutral
43.0 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
44
1Yr Price target upside is 27%
19 analysts

15

S

12

W

1

O

4

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..